Finance
Beta
search
Search or ask
settings
Theme
mobile
Device default
✓
dark_mode
Dark theme
light_mode
Light theme
Search labs
feedback
Send feedback
Sign in
Lists
playlist_add
New
603669
Research
603669:SHA
check_indeterminate_small
Lionco Pharmaceutical Group Co Ltd
CNÂ¥4.74
arrow_upward
+0.21%
(
+0.0100
) 1D
Jun 16, 3:00:02 PM GMT+8 · CNY
area_chart
Area
stacked_line_chart
Compare
search
close
All symbols
monitoring
Indicators
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
Symbol
Price
Change
% Change
Overview
Earnings
Financials
insights_auto
Generating top insights for 603669...
Open
CNÂ¥4.72
High
CNÂ¥4.86
Low
CNÂ¥4.64
Mkt. cap
3.34B
Avg. vol.
15.73M
Volume
17.85M
52-wk high
CNÂ¥7.05
52-wk low
CNÂ¥4.01
EPS
-CNÂ¥0.24
Shares outstanding
364.00M
No. of employees
284
Open
CNÂ¥4.72
High
CNÂ¥4.86
Low
CNÂ¥4.64
Mkt. cap
3.34B
Avg. vol.
15.73M
Volume
17.85M
52-wk high
CNÂ¥7.05
52-wk low
CNÂ¥4.01
EPS
-CNÂ¥0.24
Shares outstanding
364.00M
No. of employees
284
Related stocks
600211
Tibet Rhodiola Pharmaceutical Holding Co
CNÂ¥36.68
-1.37%
arrow_downward
603676
Tibet Weixinkang Pharmaceutical Co Ltd
CNÂ¥8.72
-1.25%
arrow_downward
002653
Haisco Pharmaceutical Group Co Ltd
CNÂ¥48.39
-1.35%
arrow_downward
301075
Tibet Duo Rui Pharmaceutical Co Ltd
CNÂ¥69.31
+0.64%
arrow_upward
News stories
From sources across the web
Yahoo Finance
·
15 minutes ago
Here Are Tuesday’s Best Wall Street Analyst Research Calls: Dynatrace, Emerson Electric, Exxon Mobil, Flutter Entertainment, Genuine Parts, nVent Electric, Palantir Technologies, Roku, and More
Quartz
·
16 minutes ago
Dow record, SpaceX rally, Federal Reserve decision 2026
Barron's
·
38 minutes ago
S&P 500 Futures Rise in Premarket Trading; Western Digital, Agilent Technologies Lead
WSJ
·
14 hours ago
Stocks Have Even More Room to Fly if Hormuz Reopens
Show more
About Lionco Pharmaceutical Group Co Ltd
CEO
-
Employees
284
Founded
Dec 24, 2003
Headquarters
-
Sector
Pharmaceutical industry
Website
lingkang.com.cn
Previous reports
All values in CNY
Loading Previous Earnings...
Income statement
Balance sheet
Cash flow
Income statement
Revenue
Net income
calendar_month
Quarterly
Quarterly
Annual
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
121.49M
110.25M
40.62M
86.54M
Cost of goods sold
104.96M
17.03M
23.46M
61.57M
Cost of revenue
104.96M
17.03M
23.46M
61.57M
Research and development expenses
1.22M
952.94K
6.72M
2.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.27M
95.07M
82.68M
13.94M
Operating expense
40.09M
86.40M
84.42M
16.18M
Total operating expenses
145.05M
103.43M
107.88M
77.75M
Operating income
-23.56M
6.83M
-67.26M
8.78M
Other non operating income
1.34M
1.44M
-62.12M
-7.40M
EBT including unusual items
-17.23M
1.46M
-159.01M
3.15M
EBT excluding unusual items
-27.33M
3.14M
-114.15M
1.25M
Income tax expense
-116.27K
232.92K
-275.47K
198.00K
Effective tax rate
0.67%
15.92%
0.17%
6.28%
Other operating expenses
1.09M
-10.11M
849.10K
186.27K
Net income
-17.11M
1.23M
-158.74M
2.96M
Net profit margin
-14.09%
1.12%
-390.75%
3.42%
Earnings per share
-
-
-
-
Interest and investment income
93.19K
40.15K
15.44M
-
Interest expense
-5.21M
-5.16M
-205.13K
-
Net interest expenses
-5.11M
-5.12M
15.23M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.10M
14.04M
-59.49M
16.55M
Gain or loss from assets sale
49.32K
-49.32K
-3.53M
-
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer
Research
edit_square
New thread
notes_spark
Thread history
close
Collapse
expand_content
Expand
add
Add Tool
travel_explore
Deep Search
arrow_upward
Ask AI
search_spark
AI content may include mistakes.
Learn more
Help
Send feedback
Privacy
Terms
Disclaimer